We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.03B
1-Year Est. Return 47.81%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+47.81%
3 Year Est. Return
+131.37%
5 Year Est. Return
+161.39%
10 Year Est. Return
+590.42%
AUM
$1.76B
AUM Growth
-$1.07B
Cap. Flow
-$141M
Cap. Flow %
-8.06%
Top 10 Hldgs %
56.01%
Holding
65
New
13
Increased
8
Reduced
10
Closed
15

Sector Composition

Rank Sector Weight
1 Miscellaneous 32.48%
2 Healthcare 16.77%
3 Financials 13.94%
4 Energy 9.69%
5 Consumer Staples 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIBX
51
DELISTED
TIBCO SOFTWARE INC
TIBX
-1,200,000
Closed -$28.4M

Similar funds

Empyrean Capital Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Empyrean Capital Partners held 65 positions worth $1.76B, down 38% from $2.83B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Empyrean Capital Partners withdrew a net $141M in Q4 2014, closing 15 positions and reducing 10 holdings. Its most notable exit was UnitedHealth, an estimated $118M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, down from 59% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Empyrean Capital Partners opened a new position in Allergan plc worth $140M.

  • Empyrean Capital Partners's largest Q4 2014 buy was Allergan plc: 544,000 shares worth $140M.
  • Empyrean Capital Partners added most to Investors Bancorp, Inc. in Q4 2014, an estimated $74.9M increase.
  • Empyrean Capital Partners's biggest Q4 2014 reduction was Williams Companies, cutting an estimated $114M.
  • Empyrean Capital Partners fully exited UnitedHealth in Q4 2014, selling an estimated $118M.
  • Empyrean Capital Partners's ten largest holdings make up 56% of its $1.76B portfolio in Q4 2014.
  • Empyrean Capital Partners opened 13 new positions and closed 15 in Q4 2014.
  • Empyrean Capital Partners's portfolio value fell 38% quarter-over-quarter to $1.76B.

Based on Empyrean Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.